Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novel monoclonal antibody efficacy in a humanized mouse psoriasis model
NL-OMON34037Recruiting
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Trial of adalimumab and ustekinumab in psoriasis and plaque psoriasis, sponsored by Boehringer Ingelheim. Primary endpoints: Effect on psoriatic process in transplanted biopsies and Epidermal thickness. Started Feb 2011; status: recruiting.
02
Drugs
adalimumabustekinumab
03
Conditions
psoriasisplaque psoriasis
Beyond the preview
Go deeper on NL-OMON34037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34037.